• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For November 13, 2023

    11/13/23 6:40:53 AM ET
    $AACG
    $ABL
    $ABOS
    $ACIC
    Other Consumer Services
    Real Estate
    Investment Managers
    Finance
    Get the next $AACG alert in real time by email

    Companies Reporting Before The Bell

    • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter.

    • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

    • IM Cannabis (NASDAQ:IMCC) is estimated to report quarterly loss at $0.21 per share on revenue of $13.30 million.

    • Kamada (NASDAQ:KMDA) is expected to report earnings for its third quarter.

    • Broadwind (NASDAQ:BWEN) is projected to report quarterly earnings at $0.08 per share on revenue of $58.22 million.

    • Moleculin Biotech (NASDAQ:MBRX) is likely to report earnings for its third quarter.

    • Modiv Industrial (NYSE:MDV) is likely to report earnings for its third quarter.

    • Roivant Sciences (NASDAQ:ROIV) is estimated to report quarterly loss at $0.31 per share on revenue of $30.12 million.

    • Gracell Biotechnologies (NASDAQ:GRCL) is expected to report earnings for its third quarter.

    • Altus Power (NYSE:AMPS) is projected to report quarterly earnings at $0.08 per share on revenue of $52.11 million.

    • RLX Technology (NYSE:RLX) is likely to report quarterly earnings at $0.01 per share on revenue of $71.97 million.

    • Moving iMage Technologies (AMEX:MITQ) is expected to report earnings for its first quarter.

    • Acumen Pharmaceuticals (NASDAQ:ABOS) is estimated to report earnings for its third quarter.

    • Theriva Biologics (AMEX:TOVX) is likely to report earnings for its third quarter.

    • Edible Garden AG (NASDAQ:EDBL) is projected to report earnings for its third quarter.

    • Virios Therapeutics (NASDAQ:VIRI) is expected to report earnings for its third quarter.

    • Akoustis Technologies (NASDAQ:AKTS) is projected to report quarterly loss at $0.18 per share on revenue of $7.08 million.

    • Jerash Holdings (US) (NASDAQ:JRSH) is likely to report quarterly earnings at $0.07 per share on revenue of $36.70 million.

    • Celcuity (NASDAQ:CELC) is likely to report earnings for its third quarter.

    • Twin Vee PowerCats (NASDAQ:VEEE) is likely to report earnings for its third quarter.

    • Capital Product Partners (NASDAQ:CPLP) is expected to report quarterly earnings at $0.74 per share on revenue of $88.24 million.

    • Henry Schein (NASDAQ:HSIC) is expected to report quarterly earnings at $1.32 per share on revenue of $3.21 billion.

    • Bitcoin Depot (NASDAQ:BTM) is estimated to report quarterly earnings at $0.10 per share on revenue of $187.67 million.

    • Ellington Residential (NYSE:EARN) is projected to report quarterly earnings at $0.24 per share on revenue of $640 thousand.

    • Astria Therapeutics (NASDAQ:ATXS) is expected to report earnings for its third quarter.

    • Drilling Tools Intl (NASDAQ:DTI) is projected to report earnings for its third quarter.

    • SNDL (NASDAQ:SNDL) is expected to report earnings for its third quarter.

    • N-able (NYSE:NABL) is projected to report quarterly earnings at $0.08 per share on revenue of $106.46 million.

    • Intuitive Machines (NASDAQ:LUNR) is expected to report quarterly loss at $0.24 per share on revenue of $35.50 million.

    • Genius Sports (NYSE:GENI) is likely to report quarterly loss at $0.03 per share on revenue of $100.21 million.

    • Tyson Foods (NYSE:TSN) is expected to report quarterly earnings at $0.29 per share on revenue of $13.73 billion.

    • Monday.Com (NASDAQ:MNDY) is estimated to report quarterly earnings at $0.20 per share on revenue of $182.36 million.

    • Tower Semiconductor (NASDAQ:TSEM) is expected to report quarterly earnings at $0.49 per share on revenue of $359.11 million.

    • Abacus Life (NASDAQ:ABL) is projected to report earnings for its third quarter.

    • GEO Group (NYSE:GEO) is projected to report earnings for its third quarter.

    • Fortrea Holdings (NASDAQ:FTRE) is expected to report quarterly earnings at $0.15 per share on revenue of $753.30 million.

    Companies Reporting After The Bell

    • Reliance Global Group (NASDAQ:RELI) is projected to report earnings for its third quarter.

    • SKYX Platforms (NASDAQ:SKYX) is estimated to report quarterly loss at $0.08 per share on revenue of $22.48 million.

    • Azenta (NASDAQ:AZTA) is estimated to report quarterly earnings at $0.02 per share on revenue of $163.74 million.

    • OMNIQ (NASDAQ:OMQS) is likely to report quarterly loss at $0.23 per share on revenue of $27.20 million.

    • Durect (NASDAQ:DRRX) is expected to report quarterly loss at $0.42 per share on revenue of $2.97 million.

    • 180 Degree Capital (NASDAQ:TURN) is estimated to report earnings for its third quarter.

    • ThermoGenesis Holdings (NASDAQ:THMO) is expected to report quarterly loss at $0.21 per share on revenue of $3.10 million.

    • Beauty Health (NASDAQ:SKIN) is expected to report quarterly earnings at $0.08 per share on revenue of $116.30 million.

    • Sachem Cap (AMEX:SACH) is likely to report quarterly earnings at $0.11 per share on revenue of $15.46 million.

    • Movella Holdings (NASDAQ:MVLA) is estimated to report quarterly loss at $0.10 per share on revenue of $8.62 million.

    • Gevo (NASDAQ:GEVO) is projected to report quarterly loss at $0.05 per share on revenue of $4.10 million.

    • Enviva (NYSE:EVA) is projected to report quarterly loss at $0.32 per share on revenue of $350.47 million.

    • Fisker (NYSE:FSR) is expected to report quarterly loss at $0.18 per share on revenue of $109.03 million.

    • Anterix (NASDAQ:ATEX) is projected to report quarterly loss at $0.62 per share on revenue of $1.08 million.

    • Lufax Holding (NYSE:LU) is expected to report earnings for its third quarter.

    • Telesis Bio (NASDAQ:TBIO) is projected to report quarterly loss at $0.30 per share on revenue of $7.40 million.

    • American Shared Hospital (AMEX:AMS) is expected to report earnings for its third quarter.

    • Bridger Aerospace Gr (NASDAQ:BAER) is estimated to report earnings for its third quarter.

    • Cyclacel Pharmaceuticals (NASDAQ:CYCC) is expected to report earnings for its third quarter.

    • Vicinity Motor (NASDAQ:VEV) is expected to report quarterly loss at $0.06 per share on revenue of $11.02 million.

    • Delcath Systems (NASDAQ:DCTH) is estimated to report quarterly loss at $0.52 per share on revenue of $680 thousand.

    • Acorda Therapeutics (NASDAQ:ACOR) is estimated to report earnings for its third quarter.

    • Y-mAbs Therapeutics (NASDAQ:YMAB) is expected to report quarterly loss at $0.19 per share on revenue of $20.93 million.

    • Salem Media Group (NASDAQ:SALM) is likely to report quarterly loss at $0.04 per share on revenue of $65.23 million.

    • Elutia (NASDAQ:ELUT) is estimated to report quarterly loss at $0.54 per share on revenue of $7.30 million.

    • Ampco-Pittsburgh (NYSE:AP) is projected to report earnings for its third quarter.

    • ATA Creativity Glb (NASDAQ:AACG) is projected to report earnings for its third quarter.

    • Spero Therapeutics (NASDAQ:SPRO) is estimated to report quarterly loss at $0.03 per share on revenue of $14.97 million.

    • Eyenovia (NASDAQ:EYEN) is likely to report quarterly loss at $0.17 per share on revenue of $200 thousand.

    • Biora Therapeutics (NASDAQ:BIOR) is likely to report earnings for its third quarter.

    • DiaMedica Therapeutics (NASDAQ:DMAC) is expected to report earnings for its third quarter.

    • Navigator Holdings (NYSE:NVGS) is expected to report quarterly earnings at $0.29 per share on revenue of $122.07 million.

    • Investcorp Credit (NASDAQ:ICMB) is estimated to report quarterly earnings at $0.14 per share on revenue of $6.64 million.

    • Acacia Research (NASDAQ:ACTG) is estimated to report quarterly earnings at $0.12 per share on revenue of $8.00 million.

    • NexGel (NASDAQ:NXGL) is likely to report earnings for its third quarter.

    • OneConnect Financial Tech (NYSE:OCFT) is likely to report quarterly loss at $0.01 per share on revenue of $135.00 million.

    • Zomedica (AMEX:ZOM) is projected to report earnings for its third quarter.

    • Peraso (NASDAQ:PRSO) is expected to report quarterly loss at $0.10 per share on revenue of $3.05 million.

    • Owlet (NYSE:OWLT) is projected to report quarterly loss at $0.36 per share on revenue of $16.42 million.

    • TeraWulf (NASDAQ:WULF) is projected to report quarterly loss at $0.04 per share on revenue of $20.20 million.

    • Southland Holdings (AMEX:SLND) is projected to report earnings for its third quarter.

    • Spectral AI (NASDAQ:MDAI) is estimated to report earnings for its third quarter.

    • Lucid Diagnostics (NASDAQ:LUCD) is likely to report quarterly loss at $0.27 per share on revenue of $780 thousand.

    • Bioceres Crop Solutions (NASDAQ:BIOX) is estimated to report quarterly earnings at $0.06 per share on revenue of $126.94 million.

    • Clearside Biomedical (NASDAQ:CLSD) is expected to report quarterly loss at $0.15 per share on revenue of $160 thousand.

    • Aspira Womens Health (NASDAQ:AWH) is estimated to report quarterly loss at $0.51 per share on revenue of $2.91 million.

    • Hall Of Fame Resort (NASDAQ:HOFV) is projected to report quarterly loss at $2.48 per share on revenue of $9.80 million.

    • Exagen (NASDAQ:XGN) is estimated to report quarterly loss at $0.46 per share on revenue of $10.33 million.

    • Pulse Biosciences (NASDAQ:PLSE) is expected to report earnings for its third quarter.

    • Grindr (NYSE:GRND) is estimated to report earnings for its third quarter.

    • American Coastal (NASDAQ:ACIC) is likely to report earnings for its third quarter.

    • OPAL Fuels (NASDAQ:OPAL) is estimated to report quarterly earnings at $0.09 per share on revenue of $78.42 million.

    • Sanara MedTech (NASDAQ:SMTI) is estimated to report quarterly earnings at $0.00 per share on revenue of $18.80 million.

    • Asure Software (NASDAQ:ASUR) is likely to report quarterly earnings at $0.06 per share on revenue of $26.46 million.

    • Harrow (NASDAQ:HROW) is projected to report quarterly earnings at $0.05 per share on revenue of $37.69 million.

    • icad (NASDAQ:ICAD) is estimated to report quarterly loss at $0.08 per share on revenue of $6.27 million.

    • Li-Cycle Holdings (NYSE:LICY) is expected to report quarterly loss at $0.24 per share on revenue of $2.99 million.

    • Danaos (NYSE:DAC) is likely to report quarterly earnings at $7.39 per share on revenue of $238.30 million.

    • Ryvyl (NASDAQ:RVYL) is estimated to report quarterly loss at $0.40 per share on revenue of $15.70 million.

    • Vicarious Surgical (NYSE:RBOT) is expected to report earnings for its third quarter.

    • Xperi (NYSE:XPER) is projected to report quarterly loss at $0.09 per share on revenue of $127.86 million.

    • AECOM (NYSE:ACM) is expected to report quarterly earnings at $0.98 per share on revenue of $3.69 billion.

    • Faraday Future (NASDAQ:FFIE) is projected to report quarterly loss at $3.20 per share on revenue of $3.00 million.

    • Rumble (NASDAQ:RUM) is projected to report quarterly loss at $0.17 per share on revenue of $25.38 million.

    • Sun Life Financial (NYSE:SLF) is expected to report earnings for its third quarter.

    • Cara Therapeutics (NASDAQ:CARA) is expected to report quarterly loss at $0.52 per share on revenue of $9.95 million.

    • XP (NASDAQ:XP) is estimated to report quarterly earnings at $0.41 per share on revenue of $760.84 million.

    • Star Bulk Carriers (NASDAQ:SBLK) is estimated to report quarterly earnings at $0.36 per share on revenue of $162.01 million.

    • Afya (NASDAQ:AFYA) is expected to report quarterly earnings at $0.27 per share on revenue of $140.74 million.

    • Hesai Gr (NASDAQ:HSAI) is estimated to report quarterly loss at $0.21 per share on revenue of $50.12 million.

    • Markforged Holding (NYSE:MKFG) is estimated to report quarterly loss at $0.07 per share on revenue of $25.46 million.

    • ImmuCell (NASDAQ:ICCC) is estimated to report earnings for its third quarter.

    • Beyond Air (NASDAQ:XAIR) is expected to report quarterly loss at $0.47 per share on revenue of $480 thousand.

    • Astra Space (NASDAQ:ASTR) is projected to report earnings for its third quarter.

    • Adecoagro (NYSE:AGRO) is expected to report earnings for its third quarter.

    • Dragonfly Energy Hldgs (NASDAQ:DFLI) is projected to report quarterly loss at $0.20 per share on revenue of $17.60 million.

    • Gladstone Cap (NASDAQ:GLAD) is projected to report quarterly earnings at $0.29 per share on revenue of $23.37 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AACG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AACG
    $ABL
    $ABOS
    $ACIC

    CompanyDatePrice TargetRatingAnalyst
    Grindr Inc.
    $GRND
    2/24/2026$14.00Equal-Weight
    Morgan Stanley
    Afya Limited
    $AFYA
    2/24/2026$17.00Buy → Neutral
    BofA Securities
    monday.com Ltd.
    $MNDY
    2/23/2026$80.00Buy → Hold
    Jefferies
    Henry Schein Inc.
    $HSIC
    2/23/2026$100.00Neutral → Outperform
    Robert W. Baird
    N-able Inc.
    $NABL
    2/20/2026$9.50 → $5.50Market Perform
    BMO Capital Markets
    Afya Limited
    $AFYA
    2/13/2026$16.00Equal-Weight → Underweight
    Morgan Stanley
    Hesai Group
    $HSAI
    2/10/2026$31.50Outperform
    Macquarie
    monday.com Ltd.
    $MNDY
    2/10/2026$80.00Buy → Hold
    Loop Capital
    More analyst ratings

    $AACG
    $ABL
    $ABOS
    $ACIC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for HEPZATO issued to DELCATH SYSTEMS INC

    Submission status for DELCATH SYSTEMS INC's drug HEPZATO (SUPPL-7) with active ingredient MELPHALAN HYDROCHLORIDE has changed to 'Approval' on 10/01/2024. Application Category: NDA, Application Number: 201848, Application Classification: REMS

    10/2/24 4:43:10 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care

    FDA Approval for HEPZATO issued to DELCATH SYSTEMS INC

    Submission status for DELCATH SYSTEMS INC's drug HEPZATO (SUPPL-3) with active ingredient MELPHALAN HYDROCHLORIDE has changed to 'Approval' on 05/22/2024. Application Category: NDA, Application Number: 201848, Application Classification: Labeling

    5/23/24 10:32:08 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care

    FDA Approval for DANYELZA issued to Y-MABS THERAPEUTICS INC

    Submission status for Y-MABS THERAPEUTICS INC's drug DANYELZA (SUPPL-8) with active ingredient NAXITAMAB-GQGK has changed to 'Approval' on 03/20/2024. Application Category: BLA, Application Number: 761171, Application Classification:

    3/21/24 10:20:07 AM ET
    $YMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AACG
    $ABL
    $ABOS
    $ACIC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mach 2 and Beyond: Aerospace Enters Its Biggest Spending Cycle

    Issued on behalf of Starfighters SpaceVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity Insider News Commentary -- Congress approved $839 billion in Pentagon funding for fiscal 2026, $8 billion more than the Department of Defense requested, with billions earmarked for space, missile defense, and advanced aerospace systems[1]. The Pentagon's $152 billion reconciliation spending plan allocates $2.2 billion specifically to accelerate hypersonic defense systems and $5.6 billion for space-based interceptors[2]. Companies positioned across aerospace testing, defense technology, and space infrastructure include Starfighters Space (NYSE-A: FJET), Kratos Defense (NASDAQ:KTOS), V2X (NYSE:VVX), Redwire (NYS

    2/27/26 11:24:00 AM ET
    $FJET
    $KTOS
    $LUNR
    Air Freight/Delivery Services
    Consumer Discretionary
    Military/Government/Technical
    Industrials

    NYSE Content Update: Grindr Reports 28% Full Year Revenue Growth in Q4 Earnings

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 27, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Caroline Woods delivers the pre-market update on February 27thStocks are mixed Friday morning as investors digest fresh economic data including the January PPI Report and the latest comments from Federal Reserve policymakers.Grindr (NYSE:GRND) released its latest earnings following Thursday's market close, revealing that its revenue jumped by 28% in 2025.Zeta Global (NYSE:ZETA

    2/27/26 8:55:00 AM ET
    $GRND
    $ICE
    $QNC
    Computer Software: Programming Data Processing
    Technology
    Investment Bankers/Brokers/Service
    Finance

    Edible Garden to Showcase Zero-Waste Inspired® Platform and Announce Major Nutrition Platform Expansion at Natural Products Expo West® 2026 in Anaheim, California, March 3–6

    BELVIDERE, NJ, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leader in controlled environment agriculture (CEA) and producer of locally grown, organic, and sustainable produce and products, today announced its participation in Natural Products Expo West® 2026, taking place at the Anaheim Convention Center in Anaheim, California from March 3–6, 2026. The Company will exhibit at Booth #N1546, where it will highlight the strength of its vertically integrated growth platform and announce a significant strategic initiative reflecting the next stage of its corporate development. Natural Products Expo West® 2026, produ

    2/27/26 8:02:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    $AACG
    $ABL
    $ABOS
    $ACIC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley initiated coverage on Grindr with a new price target

    Morgan Stanley initiated coverage of Grindr with a rating of Equal-Weight and set a new price target of $14.00

    2/24/26 7:55:00 AM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Afya downgraded by BofA Securities with a new price target

    BofA Securities downgraded Afya from Buy to Neutral and set a new price target of $17.00

    2/24/26 7:40:53 AM ET
    $AFYA
    Other Consumer Services
    Real Estate

    Monday.com downgraded by Jefferies with a new price target

    Jefferies downgraded Monday.com from Buy to Hold and set a new price target of $80.00

    2/23/26 8:32:39 AM ET
    $MNDY
    Computer Software: Prepackaged Software
    Technology

    $AACG
    $ABL
    $ABOS
    $ACIC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Swets Larry G Jr bought $47,000 worth of shares (100,000 units at $0.47) (SEC Form 4)

    4 - Twin Vee PowerCats, Co. (0001855509) (Issuer)

    2/25/26 5:02:06 PM ET
    $VEEE
    Marine Transportation
    Industrials

    CEO & Interim CFO Visconti Joseph C bought $9,400 worth of shares (20,000 units at $0.47), increasing direct ownership by 8% to 262,914 units (SEC Form 4)

    4 - Twin Vee PowerCats, Co. (0001855509) (Issuer)

    2/25/26 5:01:09 PM ET
    $VEEE
    Marine Transportation
    Industrials

    Chief Underwriting Officer Crawford Troy J bought $35,472 worth of shares (3,200 units at $11.09), increasing direct ownership by 34% to 12,585 units (SEC Form 4)

    4 - AMERICAN COASTAL INSURANCE Corp (0001401521) (Issuer)

    2/24/26 4:05:22 PM ET
    $ACIC
    Property-Casualty Insurers
    Finance

    $AACG
    $ABL
    $ABOS
    $ACIC
    SEC Filings

    View All

    Pulse Biosciences Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    2/27/26 5:26:13 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form 8-K filed by Intuitive Machines Inc.

    8-K - Intuitive Machines, Inc. (0001844452) (Filer)

    2/27/26 4:40:57 PM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    SEC Form 20-F filed by Danaos Corporation

    20-F - Danaos Corp (0001369241) (Filer)

    2/27/26 4:16:39 PM ET
    $DAC
    Marine Transportation
    Consumer Discretionary

    $AACG
    $ABL
    $ABOS
    $ACIC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, CEO Bergman Stanley M sold $2,518,741 worth of Common Stock par value $0.01 per share (31,134 units at $80.90) and sold $1,463,592 worth of shares (17,997 units at $81.32), decreasing direct ownership by 3% to 309,092 units (SEC Form 4)

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    2/27/26 4:31:42 PM ET
    $HSIC
    Medical Specialities
    Health Care

    Chief Executive Officer Yon Seth D covered exercise/tax liability with 873 shares, decreasing direct ownership by 0.97% to 88,978 units (SEC Form 4)

    4 - Sanara MedTech Inc. (0000714256) (Issuer)

    2/27/26 4:27:51 PM ET
    $SMTI
    Industrial Specialties
    Health Care

    Chief Operating Officer Waldrop Jacob A. covered exercise/tax liability with 714 shares, decreasing direct ownership by 6% to 10,799 units (SEC Form 4)

    4 - Sanara MedTech Inc. (0000714256) (Issuer)

    2/27/26 4:23:31 PM ET
    $SMTI
    Industrial Specialties
    Health Care

    $AACG
    $ABL
    $ABOS
    $ACIC
    Financials

    Live finance-specific insights

    View All

    AECOM to provide design, environmental, and project management services for Sound Transit's Seattle-area regional transit expansion

    AECOM (NYSE:ACM), the trusted global infrastructure leader, today announced it has been selected by Sound Transit to deliver design, planning and environmental services, along with project and construction management (PMCM) services through three multiple-award task order contracts (MATOCs). These contracts will provide a basis for the next wave of planning, design, and delivery for the Seattle region's light rail, commuter rail, and bus network. As the prime firm on the five-year Design MATOC, AECOM will lead the delivery of civil and structural engineering work, with a project scope ranging from preliminary engineering to full design development. In aggregate, Sound Transit has issued a

    2/27/26 6:55:00 AM ET
    $ACM
    Military/Government/Technical
    Consumer Discretionary

    Sachem Capital Sets Dates for Fourth Quarter and Full Year 2025 Earning Release and Conference Call

    BRANFORD, Conn., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Sachem Capital Corp. (NYSE:SACH) (the "Company") announced today that the Company will release its fourth quarter and full year 2025 financial results after market closes on Thursday, March 12, 2026. A webcast and conference call to discuss the results will be held on Friday, March 13, 2026, at 8:00 a.m. Eastern Time. Webcast:A webcast of the conference call will be available on the Investors section of the Company's website www.sachemcapitalcorp.com. To listen to the live broadcast, go to the site at least 15 minutes prior to the scheduled start time to register and install any necessary audio software. To Participate in the Telephone C

    2/26/26 4:15:00 PM ET
    $SACH
    Real Estate Investment Trusts
    Real Estate

    Grindr Inc. Delivers 28% Full Year 2025 Revenue Growth

    Introduces 2026 Guidance: Revenue Greater than $528 Million and Adjusted EBITDA Greater than $217 Million Announces $400 Million Increase to Common Stock Repurchase Program; Program Extended to March 2029 Grindr Inc. (NYSE:GRND) ("Grindr" or the "Company"), the Global Gayborhood in Your PocketTM, today posted its financial results for the fourth quarter and fiscal year ended December 31, 2025, in a Letter to Shareholders. The Letter to Shareholders can be accessed on Grindr's Investor Relations website: https://investors.grindr.com/. The Company also announced that its Board of Directors has authorized an increase in the Company's share repurchase program by up to an additional $400 m

    2/26/26 4:05:00 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    $AACG
    $ABL
    $ABOS
    $ACIC
    Leadership Updates

    Live Leadership Updates

    View All

    Diality Appoints Peter Donato as Chief Financial Officer

    Life sciences veteran brings private and public sector expertise to company in midst of growth trajectory Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System while preparing for a limited market release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224064413/en/Diality CFO Peter Donato. Donato joins Diality with nearly 35 years of financial leadershi

    2/24/26 7:05:00 AM ET
    $MYGN
    $STIM
    $TFX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Medical/Dental Instruments
    Pharmaceuticals and Biotechnology

    American Coastal Insurance Corporation Announces the Appointment of Troy Crawford as Chief Underwriting Officer

    ST. PETERSBURG, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- American Coastal Insurance Corporation (Nasdaq Ticker: ACIC) ("the Company", "American Coastal" or "ACIC"), the insurance holding company of American Coastal Insurance Company ("AmCoastal"), announced today that Troy Crawford, MBA, CPCU, CLU, was appointed as Chief Underwriting Officer of ACIC. Crawford was appointed as Chief Underwriting Officer of AmCoastal in January 2025, overseeing underwriting strategy, risk selection, and portfolio performance across AmCoastal's commercial insurance operations. Mr. Crawford has more than 30 years of experience leading large property and casualty P&L portfolios at leading national and regional

    2/20/26 4:05:00 PM ET
    $ACIC
    Property-Casualty Insurers
    Finance

    DentaQuest's Chief Dental Officer Named to TeamSmile Board of Directors

    Dr. Todd Gray's passion for oral healthcare aligns with Sun Life and TeamSmile missions to provide children in need with life-changing dental careWELLESLEY, Mass., Feb. 19, 2026 /PRNewswire/ -- Dr. Todd Gray, chief dental officer for Sun Life U.S. including DentaQuest, recently joined TeamSmile's Board of Directors, reinforcing both a personal and professional dedication to improving oral health for all. DentaQuest has been the exclusive national dental insurance partner of TeamSmile since 2017.TeamSmile is the nation's premier advocacy group that partners oral health profession

    2/19/26 10:00:00 AM ET
    $SLF
    Life Insurance
    Finance

    $AACG
    $ABL
    $ABOS
    $ACIC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Exagen Inc.

    SC 13G/A - EXAGEN INC. (0001274737) (Subject)

    12/12/24 5:00:54 PM ET
    $XGN
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Lucid Diagnostics Inc.

    SC 13D/A - Lucid Diagnostics Inc. (0001799011) (Subject)

    12/12/24 4:30:32 PM ET
    $LUCD
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by Anterix Inc.

    SC 13D/A - Anterix Inc. (0001304492) (Subject)

    12/9/24 8:45:15 PM ET
    $ATEX
    Telecommunications Equipment
    Telecommunications